As of June 30, 2024, Genetic Technologies Limited has 132.22M shares outstanding.
| Shares Outstanding | 132.22M |
These figures are as of June 30, 2024.
| PB Ratio | 5.85 |
| P/TBV Ratio | -34.05 |
As of June 30, 2024, Genetic Technologies Limited maintains a current ratio of 0.88, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.88 |
| Quick Ratio | 0.75 |
| Debt / Equity | 47.81 |
These figures cover the twelve months ended June 30, 2024. Total shareholder yield is negative at -26.35, meaning Genetic Technologies Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -26.35 |
Genetic Technologies Limited's most recent stock split took place on August 7, 2024 with a 43:45 split ratio.
| Last Split Date | 8/7/2024 |
| Split Ratio | 43:45 |
As of June 30, 2024, Genetic Technologies Limited has an Altman Z-Score of -56.31, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -56.31 |
Already premium?